Rabinowitz Michael
SEC CIK 1767090 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORMP | ORAMED PHARMACEUTICALS INC. | Chief Commercial Off | 109.5K | — | — | 3 | 2021-08-04 | 2022-01-03 |
Most active insiders at ORMP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hexter Joshua | COO, CBO | — | $611.4K |
| 2 | Gabay Avraham | CFO | — | $330.7K |
| 3 | Reznick Yehuda | Dir | — | — |
| 4 | Aghion Daniel | Dir | — | — |
| 5 | Shapiro Benjamin | Dir | — | — |
| 6 | Mayer Arie | Dir | — | — |
| 7 | Kidron Miriam | CSO, Dir | — | — |
| 8 | KIDRON NADAV | Pres, CEO, Dir | — | — |
Rabinowitz Michael made no open-market trades at ORMP in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-05 | 2022-01-03 | ORMP | ORAMED PHARMACEUTICALS INC. | Rabinowitz Michael | Chief Commercial Off | A - Grant | — | +19.0K | 109.5K | +21% | — |
| 2021-12-30 | 2021-12-28 | ORMP | ORAMED PHARMACEUTICALS INC. | Rabinowitz Michael | Chief Commercial Off | F - Tax | $12.98 | -9,532 | 90.5K | -10% | -$123.7K | |
| D | 2021-08-06 | 2021-08-04 | ORMP | ORAMED PHARMACEUTICALS INC. | Rabinowitz Michael | Chief Commercial Off | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations